Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-04

Clinical Trial Update: Decreasing Postoperative Complications by Goal-Directed Fluid Therapy During Esophageal Resection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial examining goal-directed fluid therapy to reduce postoperative complications after esophageal resection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Linkoeping | Conditions: Esophageal Cancer | Phase 4 | Status: COMPLETED